Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/16/2019 07/17/2019 07/18/2019 07/19/2019 07/22/2019 Date
46.775(c) 45.63(c) 45.325(c) 45.03(c) 44.875 Last
1 220 229 1 727 748 1 448 972 1 865 915 1 456 929 Volume
-0.05% -2.45% -0.67% -0.65% -0.34% Change
More quotes
Financials (EUR)
Sales 2019 35 381 M
EBIT 2019 4 630 M
Net income 2019 1 883 M
Debt 2019 19 733 M
Yield 2019 1,79%
Sales 2020 37 138 M
EBIT 2020 4 921 M
Net income 2020 1 996 M
Debt 2020 18 288 M
Yield 2020 1,89%
P/E ratio 2019 13,3x
P/E ratio 2020 12,5x
EV / Sales2019 1,27x
EV / Sales2020 1,17x
Capitalization 25 080 M
More Financials
Company
Fresenius specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (52.4%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis,... 
More about the company
Surperformance© ratings of Fresenius SE & Co. KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on FRESENIUS SE & CO. KGAA
07/18CVS to Test a Device For Dialysis at Home -- WSJ
DJ
07/09Drugmakers Rise After Trump Pricing Rule Is Blocked
DJ
07/02FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by ..
EQ
07/01FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
06/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
06/27FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
06/21FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
06/14FRESENIUS : Medical Care successfully places USD bonds
PU
06/12FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
06/11FRESENIUS : Kabi Introduces Neostigmine Methylsulfate Injection, USP Simplist Pr..
AQ
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Stock Trading Strategies
FRESENIUS - 02/04
A trend reversal is in sight
BUY
More Stock Trading Analysis
Sector news : Hospitals, Clinics & Primary Care Services
07/18CVS to Test a Device For Dialysis at Home -- WSJ
DJ
07/17Medical Distributors Stocks Fall After Opioid Data Reports
DJ
07/17Medical Distributors Stocks Fall After Opioid Data Reports
DJ
07/17CVS HEALTH : Begins Clinical Trial for Home-Dialysis Device
DJ
07/11Health-Care Rally Helps Lift Dow Over 27000
DJ
More sector news : Hospitals, Clinics & Primary Care Services
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 56,64  €
Last Close Price 45,04  €
Spread / Highest target 57,5%
Spread / Average Target 25,8%
Spread / Lowest Target -27,9%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors